Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - OMNIQ Corp. (0000278165) (Filer)
OMNIQ Corp. filed a Form 8-K on September 29, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Global Business Travel Group, Inc. (0001820872) (Filer)
Global Business Travel Group, Inc. filed an 8-K reporting entry into and termination of material definitive agreements, completion of an acquisition or asset disposition, creation of a direct financial obligation, a delisting notice, and material modifications to security holder rights.
- 8-K - Apollo Realty Income Solutions, Inc. (0001882850) (Filer)
Apollo Realty Income Solutions, Inc. filed a Form 8-K on September 29, 2026, reporting the departure, election, or appointment of certain directors and officers and disclosing related compensatory arrangements.
- 8-K - CareCloud, Inc. (0001582982) (Filer)
CareCloud, Inc. filed a Form 8-K on September 29, 2026, disclosing director and officer departures, elections, appointments, related compensation arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - Host Digital Inc. (0001948864) (Filer)
Host Digital Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Nauticus Robotics, Inc. (0001849820) (Filer)
Nauticus Robotics, Inc. filed a Form 8-K on September 29, 2026, disclosing entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)
Ensysce Biosciences filed a Form 8-K on September 29, 2026, reporting amendments to its articles of incorporation or bylaws and a change in fiscal year, and providing financial statements and related exhibits.
- 8-K - OneMedNet Corp (0001849380) (Filer)
OneMedNet Corp filed a Form 8-K on September 29, 2026 reporting material modifications to security-holder rights, amendments to its articles of incorporation and bylaws, including a change in fiscal year, and providing related financial statements and exhibits.
- 8-K - PRA GROUP INC (0001185348) (Filer)
PRA Group Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001193125-26-406082.
- 8-K - NewAmsterdam Pharma Co N.V. (0001936258) (Filer)
NewAmsterdam Pharma Co N.V. filed a Form 8-K with the SEC on September 29, 2026, reporting other events under Item 8.01 and providing financial statements and related exhibits under Item 9.01.
- 8-K - PNC FINANCIAL SERVICES GROUP, INC. (0000713676) (Filer)
PNC Financial Services Group filed a Form 8-K on September 29, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Flash Sports & Media Holdings, Inc. (0001706524) (Filer)
Flash Sports & Media Holdings filed a Form 8-K on September 29, 2026, reporting a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - ALASKA AIR GROUP, INC. (0000766421) (Filer)
Alaska Air Group, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - FORD MOTOR CREDIT CO LLC (0000038009) (Filer)
Ford Motor Credit Co. LLC filed a Form 8-K on September 29, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Keros Therapeutics, Inc. (0001664710) (Filer)
Keros Therapeutics, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure and financial statements with related exhibits.
- 8-K - FIRST UNITED CORP/MD/ (0000763907) (Filer)
First United Corp filed a Form 8-K on September 29, 2026 reporting the departure, election, or appointment of directors and certain officers, and disclosing compensatory arrangements for those officers.
- 8-K - TOP Financial Group Ltd (0001848275) (Filer)
TOP Financial Group Ltd filed a Form 8-K on September 29, 2026, reporting director/officer departures, elections, appointments and related compensation arrangements, and including its financial statements and exhibits.
- 8-K - Imunon, Inc. (0000749647) (Filer)
Imunon, Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, amendments to its articles of incorporation and bylaws including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - SurgePays, Inc. (0001392694) (Filer)
SurgePays, Inc. filed an 8-K on September 29, 2026 reporting a notice of delisting or failure to satisfy a continued listing rule and indicating a planned transfer of its listing.
- 8-K - Bloomin' Brands, Inc. (0001546417) (Filer)
Bloomin' Brands filed an 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)
Allarity Therapeutics filed a Form 8-K on September 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - ATOSSA THERAPEUTICS, INC. (0001488039) (Filer)
Atossa Therapeutics, Inc. filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - TransDigm Group INC (0001260221) (Filer)
TransDigm Group filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- Two Indian Nationals Charged in Connection with Transnational Counterfeit Ozempic Scheme
A federal grand jury in the Middle District of Florida charged Indian nationals Swapnadip Roy, 33, and Vicky Ramancha, 37, with conspiracy and smuggling in an alleged transnational counterfeit Ozempic prescription-drug distribution scheme.
- Illegal Alien from Venezuela Charged with Assaulting and Resisting a Federal Officer in Austin
A Venezuelan national who entered the U.S. illegally appeared in federal court in Austin and was charged with assaulting, resisting, interfering with and impeding a federal officer, according to U.S. Attorney Justin R. Simmons.
- Arizona CEO Pleads Guilty to Embezzling Over $8.8M from Employee Benefit Plans
James Vincent Campbell, 49, of Scottsdale, Arizona, pleaded guilty in the U.S. District Court for Maryland to embezzling more than $8.8 million from an Employee Retirement Income Security Act (ERISA) benefit plan.
- DOJ’s Fraud Division Uncovers $1.34M in Stolen Social Security Benefits in One Month Takedown, Including Fraudster Who Allegedly Hid Deceased Mother in Garage Freezer
The Justice Department’s National Fraud Enforcement Division reported a one-month takedown that recovered $1.34 million in fraudulent Social Security benefits, citing cases such as a suspect who allegedly concealed his deceased mother in a garage freezer.
- Mexican Couple Extradited from Mexico for Smuggling Unaccompanied Alien Children into the United States
Two Mexican nationals were extradited from Mexico and arraigned in the U.S. Western District of Texas on charges of smuggling unaccompanied alien children into the United States.
- 8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Unicycive Therapeutics filed a Form 8-K reporting director/officer departures and appointments, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - SOUNDTHINKING, INC. (0001351636) (Filer)
SoundThinking, Inc. filed a Form 8-K reporting a material definitive agreement, the departure and appointment of directors and officers with related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.